TENS Treatment Plus Ibuprofen for the Treatment of Acute Back Pain in the ED
Primary Purpose
Low Back Pain
Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TENS
Sponsored by
About this trial
This is an interventional treatment trial for Low Back Pain focused on measuring TENS
Eligibility Criteria
Inclusion Criteria:
- Patients 18 years to 65 years of age presenting to the emergency room with a primary complaint of low back pain.
- Patient is receiving 800mg dose of ibuprofen as part of their treatment regimen for back pain
- Back pain new in the last 48 hours
- Deemed by the treating physician to have musculoskeletal back pain, and no central/peripheral nervous system pathology as the cause of their pain.
Exclusion Criteria:
- Allergy to ibuprofen.
- Hypotension (MAP <65 or Systolic BP <100), fever, tachycardia
- Paresthesias, isolated motor weakness, or objective sensory deficit on physical exam
- Radicular symptoms
- Urinary incontinence or retention
- Bowel incontinence
- Unexplained weight loss of >15 lbs in the last 3 months.
- Multiple primary complaints in the ED.
- Received Analgesia other than Ibuprofen as part of their ED work up.
- Taken prescription strength pain medication within the last 12 hours for any condition.
- History of active malignancy, HIV, organ transplantation, active hemodialysis
- Currently pregnant
- Nursing home residents
- Currently in police custody
Sites / Locations
- Albert Einstein Healthcare Network
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Ibuprofen and TENS plus
Ibuprofen and Sham TENS plus
Arm Description
Patients will receive 45 minutes of TENS therapy. All patients will receive ibuprofen.
Patients will receive 45 minutes of sham TENS therapy. All patients will receive ibuprofen.
Outcomes
Primary Outcome Measures
Change in visual analog scale (VAS)
Patients will have a baseline and 45 minutes VAS performed
Secondary Outcome Measures
Treatment failure
Patients requiring rescue medication after 45 minute treatment will be considered treatment failures and will receive further non study related treatment at the discretion of the treating physician
Adverse events
Any reactions to TENS application
Full Information
NCT ID
NCT02611583
First Posted
November 19, 2015
Last Updated
May 8, 2017
Sponsor
Albert Einstein Healthcare Network
1. Study Identification
Unique Protocol Identification Number
NCT02611583
Brief Title
TENS Treatment Plus Ibuprofen for the Treatment of Acute Back Pain in the ED
Official Title
Double-blind, Randomized, Placebo Controlled Trial of Transcutaneous Electrical Nerve Stimulation (TENS) Treatment Plus Ibuprofen for the Treatment of Acute Back Pain in the Emergency Department
Study Type
Interventional
2. Study Status
Record Verification Date
March 2017
Overall Recruitment Status
Withdrawn
Why Stopped
Never initiated due to lack of funding and IRB Approval
Study Start Date
June 24, 2016 (Actual)
Primary Completion Date
June 24, 2016 (Actual)
Study Completion Date
June 24, 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Albert Einstein Healthcare Network
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Patients presenting to the ED with a chief complaint of acute low back pain and whom the providing physician feels symptomatic treatment is appropriate in the ED will be screened for inclusion in the study. The purpose of the study is to compare Transcutaneous Electrical Nerve Stimulation (TENS) as an adjunct to ibuprofen in the treatment of acute low back pain in the emergency department. Therefore, the aim of this prospective, randomized, double blind study is to evaluate the efficacy of ED administered TENS in acute low back pain patients during their ED visit.
Detailed Description
The study is a double blind, randomized, placebo controlled trial. One group will receive ibuprofen and TENS. The comparison group will receive ibuprofen and sham TENS. The study primary endpoint is change in pain level on Visual Analog Scale score at 45-60 minutes after TENS start.
This is a two-arm, double blind, randomized control trial evaluating the patient perceived improvement in back pain. Patients will first fill out a Visual Analog Scale (VAS).
Patients will be randomized to one of two arms. Ibuprofen 800 mg, plus sham TENS for 45 minutes Ibuprofen 800 mg, plus TENS for 45 minutes
Patients will be given a 2nd VAS scale up to 15 minutes after the end of the TENS session. After the second VAS the patients will be finished with the study procedures and can be continued to be cared as per the discretion of their treating physician.
Our intention is to detect a 20% reduction in pain by VAS with a common standard deviation equal to the difference at the p = 0.05 level with a power of 80% using an analysis of variance (ANOVA). The calculated sample size required 28 patients per group. Considering the uncertain dropout rate, the investigators decided to enroll at least 66 patients. Baseline characteristics will be calculated to determine if groups are equal. A two-way repeated-measures ANOVA will be used to test both a trial effect and a group effect (SPSS 20, SPSS Inc., Chicago, IL). Data will be presented as means with standard deviations with 95% confidence intervals. A p< 0.05 was considered statistically significant.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain
Keywords
TENS
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Ibuprofen and TENS plus
Arm Type
Active Comparator
Arm Description
Patients will receive 45 minutes of TENS therapy. All patients will receive ibuprofen.
Arm Title
Ibuprofen and Sham TENS plus
Arm Type
Placebo Comparator
Arm Description
Patients will receive 45 minutes of sham TENS therapy. All patients will receive ibuprofen.
Intervention Type
Device
Intervention Name(s)
TENS
Intervention Description
Transcutaneous Electrical Nerve Stimulation
Primary Outcome Measure Information:
Title
Change in visual analog scale (VAS)
Description
Patients will have a baseline and 45 minutes VAS performed
Time Frame
0 minutes, 45 minutes
Secondary Outcome Measure Information:
Title
Treatment failure
Description
Patients requiring rescue medication after 45 minute treatment will be considered treatment failures and will receive further non study related treatment at the discretion of the treating physician
Time Frame
45 minutes
Title
Adverse events
Description
Any reactions to TENS application
Time Frame
60 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients 18 years to 65 years of age presenting to the emergency room with a primary complaint of low back pain.
Patient is receiving 800mg dose of ibuprofen as part of their treatment regimen for back pain
Back pain new in the last 48 hours
Deemed by the treating physician to have musculoskeletal back pain, and no central/peripheral nervous system pathology as the cause of their pain.
Exclusion Criteria:
Allergy to ibuprofen.
Hypotension (MAP <65 or Systolic BP <100), fever, tachycardia
Paresthesias, isolated motor weakness, or objective sensory deficit on physical exam
Radicular symptoms
Urinary incontinence or retention
Bowel incontinence
Unexplained weight loss of >15 lbs in the last 3 months.
Multiple primary complaints in the ED.
Received Analgesia other than Ibuprofen as part of their ED work up.
Taken prescription strength pain medication within the last 12 hours for any condition.
History of active malignancy, HIV, organ transplantation, active hemodialysis
Currently pregnant
Nursing home residents
Currently in police custody
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul G Dominici, MD
Organizational Affiliation
Albert Einstein Healthcare Network
Official's Role
Principal Investigator
Facility Information:
Facility Name
Albert Einstein Healthcare Network
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19141
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
6219588
Citation
Cypress BK. Characteristics of physician visits for back symptoms: a national perspective. Am J Public Health. 1983 Apr;73(4):389-95. doi: 10.2105/ajph.73.4.389.
Results Reference
background
PubMed Identifier
24994051
Citation
Patrick N, Emanski E, Knaub MA. Acute and chronic low back pain. Med Clin North Am. 2014 Jul;98(4):777-89, xii. doi: 10.1016/j.mcna.2014.03.005.
Results Reference
background
PubMed Identifier
353652
Citation
Thorsteinsson G, Stonnington HH, Stillwell KG, Elveback LR. The placebo effect of transcutaneous electrical stimulation. Pain. 1978 Jun;5(1):31-41. doi: 10.1016/0304-3959(78)90022-2.
Results Reference
background
PubMed Identifier
8378107
Citation
Marchand S, Charest J, Li J, Chenard JR, Lavignolle B, Laurencelle L. Is TENS purely a placebo effect? A controlled study on chronic low back pain. Pain. 1993 Jul;54(1):99-106. doi: 10.1016/0304-3959(93)90104-W.
Results Reference
background
PubMed Identifier
15995091
Citation
Bertalanffy A, Kober A, Bertalanffy P, Gustorff B, Gore O, Adel S, Hoerauf K. Transcutaneous electrical nerve stimulation reduces acute low back pain during emergency transport. Acad Emerg Med. 2005 Jul;12(7):607-11. doi: 10.1197/j.aem.2005.01.013.
Results Reference
background
Learn more about this trial
TENS Treatment Plus Ibuprofen for the Treatment of Acute Back Pain in the ED
We'll reach out to this number within 24 hrs